Common Contracts
2 similar Collaboration Agreement contracts
Co-development, co-promotion, marketing and licensing agreement for Contrave (naltrexone SR/bupropion SR)Collaboration Agreement • October 13th, 2021 • New York
Takeda Pharmaceuticals (TKPYY) will return the U.S. rights to the anti-obesity drug Contrave to its partnerOrexigen (OREX), the company announced this morning.
Co-development, co-promotion, marketing and licensing agreement for Contrave (naltrexone SR/bupropion SR)Collaboration Agreement • October 13th, 2021 • New York
Takeda Pharmaceuticals (TKPYY) will return the U.S. rights to the anti-obesity drug Contrave to its partnerOrexigen (OREX), the company announced this morning.
